imatinib mesylate has been researched along with Weight Gain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimena, G; Breccia, M; Salaroli, A; Serrao, A; Zacheo, I | 1 |
| Alimena, G; Breccia, M; Cannella, L; Carmosino, I; Frustaci, AM; Latagliata, R; Santopietro, M; Stefanizzi, C | 1 |
| Agee, S; Estis, J; Hasinoff, B; Herman, EH; Knapton, A; Lipshultz, S; Lu, QA; Rosen, E; Rosenzweig, B; Thompson, K; Todd, JA; Zhang, J | 1 |
| Aduwa, E; Apperley, JF; Foroni, L; Goldman, J; Marin, D; Milojkovic, D; Reid, A; Szydlo, R | 1 |
| Barton, JC; Jones, SC; Lamberth, WC; Reymann, MT; Scott, VC | 1 |
| Alimena, G; Breccia, M; Carmosino, I; Latagliata, R; Morano, SG; Russo, E | 1 |
6 other study(ies) available for imatinib mesylate and Weight Gain
| Article | Year |
|---|---|
Imatinib induces body mass changes in women with chronic myeloid leukemia.
Topics: Adult; Benzamides; Body Mass Index; Cohort Studies; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Prospective Studies; Pyrimidines; Retrospective Studies; Weight Gain | 2013 |
Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia.
Topics: Benzamides; Exanthema; Hemorrhage; Humans; Imatinib Mesylate; Incidence; Leukemia, Myeloid, Chronic-Phase; Muscle Cramp; Nausea; Piperazines; Pyrimidines; Remission Induction; Retrospective Studies; Weight Gain | 2008 |
A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat.
Topics: Animals; Apoptosis; Autophagy; Benzamides; Cardiotoxins; Heart Diseases; Imatinib Mesylate; Lysosomal-Associated Membrane Protein 2; Male; Muscle Cells; Myocardium; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Piperazines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Razoxane; Sarcomeres; Troponin; Weight Gain | 2011 |
Significant weight gain in patients with chronic myeloid leukemia after imatinib therapy.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Body Mass Index; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Obesity; Piperazines; Pyrimidines; Weight Gain | 2012 |
Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia.
Topics: Benzamides; Cardiac Tamponade; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Piperazines; Pyrimidines; Radiography; Weight Gain | 2002 |
Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma; Drug Eruptions; Edema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nausea; Piperazines; Pyrimidines; Skin Neoplasms; Vomiting; Weight Gain | 2005 |